Linagliptin 5mg
Linagliptin inhibits DPP-4 enzyme, increasing the levels of incretin hormones (GLP-1 and GIP) that stimulate insulin release and reduce glucagon when blood sugar is elevated.
Type 2 diabetes mellitus as monotherapy or in combination.
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
GLYJENTA 5 is a kidney-safe DPP-4 inhibitor — the preferred choice for diabetic patients with renal impairment where other diabetes medicines require dose adjustment or are contraindicated.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.